BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34073827)

  • 1. A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer.
    Piras M; Panebianco M; Garibaldi M; Roberto M; Merlonghi G; Pellegrini P; Marchetti P
    Curr Oncol; 2021 May; 28(3):1957-1961. PubMed ID: 34073827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.
    Kubeček O; Soukup T; Paulík A; Kopecký J
    BMC Cancer; 2016 Aug; 16(1):684. PubMed ID: 27561848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis.
    Duchesne M; Leonard-Louis S; Landon-Cardinal O; Anquetil C; Mariampillai K; Monzani Q; Benveniste O; Allenbach Y
    Brain Pathol; 2020 Sep; 30(5):867-876. PubMed ID: 32323412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report.
    Yoshida S; Matsumoto H; Fujita Y; Yokose K; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Yaguchi T; Aita T; Kusano M; Yamamoto T; Watanabe H; Migita K
    Tohoku J Exp Med; 2022 Apr; 256(4):303-308. PubMed ID: 35296571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatomyositis presenting as a paraneoplastic syndrome due to underlying breast cancer.
    Sandhu NP; Zakaria S; Degnim AC; Boughey JC
    BMJ Case Rep; 2011 Feb; 2011():. PubMed ID: 22714621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Seronegative Inflammatory Myositis to Dermatomyositis With Characteristic Cutaneous Features: A Case Report.
    Jevtic D; Dharmah U; Bahar M
    J Investig Med High Impact Case Rep; 2023; 11():23247096231217829. PubMed ID: 38097369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
    Shibata C; Kato J; Toda N; Imai M; Fukumura Y; Arai J; Kurokawa K; Kondo M; Takagi K; Kojima K; Ohki T; Seki M; Yoshida M; Suzuki A; Tagawa K
    J Med Case Rep; 2019 Jun; 13(1):168. PubMed ID: 31153385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic syndrome and underlying breast cancer: a worsening rash despite initiation of chemotherapy.
    Ahuja S; Makkar P; Gupta S; Vigoda I
    J Community Support Oncol; 2016 May; 14(5):229-31. PubMed ID: 27258056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare case of severe myositis as paraneoplastic syndrome on breast cancer.
    Dias LP; Faria AL; Scandiuzzi MM; Inhaia CL; Shida JY; Gebrim LH
    World J Surg Oncol; 2015 Apr; 13():134. PubMed ID: 25890160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic anti-TIF1-gamma-positive dermatomyositis as expression of cervical squamous cell carcinoma recurrence.
    van Erp MAJM; Slaats FMA; Emmen JMA; van Hamont D
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38262717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.
    Coudert B; Pierga JY; Mouret-Reynier MA; Kerrou K; Ferrero JM; Petit T; Kerbrat P; Dupré PF; Bachelot T; Gabelle P; Giard S; Coeffic D; Bougnoux P; Prevost JB; Paintaud G; Thibault G; Hernandez J; Coudert M; Arnould L; Berriolo-Riedinger A
    Lancet Oncol; 2014 Dec; 15(13):1493-1502. PubMed ID: 25456368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer and dermatomyositis: a case study and literature review.
    Hendren E; Vinik O; Faragalla H; Haq R
    Curr Oncol; 2017 Oct; 24(5):e429-e433. PubMed ID: 29089813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case in Which Breast Cancer Developed at the Same Time As Dermatomyositis, and the Onset of New Cancer Was Able to Be Predicted by the Exacerbating Skin Symptoms and Parallel Increase in the Anti-TIF1-γ Antibody Levels.
    Akagi H; Wada T
    Intern Med; 2023; 62(20):3057-3062. PubMed ID: 37839875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TIF1γ-Dermatomyositis and Sjögren's Syndrome As the Inaugural Presentation for Rectal Cancer.
    Oliveira Santos M; Santos I; Sacramento G; Oliveira R; Castanheira A
    Cureus; 2024 Mar; 16(3):e55978. PubMed ID: 38618380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatomyositis Developing Post Neoadjuvant Chemotherapy and Lumpectomy.
    Wong DE; Williams E; Warrier S
    R I Med J (2013); 2018 Aug; 101(6):34-36. PubMed ID: 30068052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy.
    Hou Y; Shao K; Yan Y; Dai T; Li W; Zhao Y; Li D; Lu JQ; Norman GL; Yan C
    J Neurol; 2022 Jan; 269(1):280-293. PubMed ID: 34021410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythroderma and extensive poikiloderma - a rare initial presentation of dermatomyositis: a case report.
    Herath HMMTB; Keragala BSDP; Pahalagamage SP; Janappriya GHCC; Kulatunga A; Gunasekera CN
    J Med Case Rep; 2018 Mar; 12(1):83. PubMed ID: 29571300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.